| Name | Title | Contact Details |
|---|
Access Managed Healthcare is a Floral Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ODS Companies is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
We bring many years of combined experience of equipment support, on-staff hospital imaging engineering and operations into a top-notch group of service and sales professionals. In-depth knowledge and customer focus is key. We handle all types of MRI and CT maintenance and services, including full system installation, rigging, de-installation, cold-head replacement and cryogen fills. These are just some of the reasons why leading hospitals and physician groups rely on East Coast Medical Systems to repair and service their imaging equipment.Our purpose is to express our diligence, knowledge and vigilance by pinpointing our customer`s needs and by addressing their problems, by hiring highly skilled engineers in order to provide an exact diagnosis and by being keenly watchful for any ensuing problems. To grow the organization properly, and maintain our reputation as being one of the highest regarded companies in our field, both by our customers and our peers.
Vono Medical Supplies is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.